ROLE OF CARDIAC BIOMARKERS IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY TREATED WITH CARDIAC MYOSIN INHIBITORS (CMI): A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Khan, Mohammad Ishrak [1 ]
Zahir, Raisa Subaita [1 ]
Martinez, Moises Abraham Vasquez [1 ]
Osorio, Paola A. Lecompte [1 ]
Aguilar-Gallardo, Jose S. [1 ]
Lorente-Ros, Marta [1 ]
Romeo, Francisco Jose [1 ]
机构：
[1] Icahn Sch Med Mt Sinai Morningside & West, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1323-123
引用
收藏
页码：530 / 530
页数：1
相关论文
共 50 条
  • [41] Role of Hypothermia in Adult Cardiac Surgery Patients: A Systematic Review and Meta-analysis
    Abbasciano, Riccardo Giuseppe
    Koulouroudias, Marinos
    Chad, Thomas
    Mohamed, Walid
    Leeman, Irene
    Pellowe, Carol
    Kunst, Gudrun
    Klein, Andrew
    Murphy, Gavin James
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (07) : 1883 - 1890
  • [42] Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis
    Briasoulis, Alexandros
    Mallikethi-Reddy, Sagar
    Palla, Mohan
    Alesh, Issa
    Afonso, Luis
    HEART, 2015, 101 (17) : 1406 - 1411
  • [43] Cardiopulmonary Exercise Test in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
    Bayonas-Ruiz, Adrian
    Munoz-Franco, Francisca M.
    Ferrer, Vicente
    Perez-Caballero, Carlos
    Sabater-Molina, Maria
    Tome-Esteban, Maria Teresa
    Bonacasa, Barbara
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (11)
  • [44] Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy A Systematic Review and Meta-Analysis
    Patel, Divyang
    Kumar, Anirudh
    Black-Maier, Eric
    Morgan, Rebecca L.
    Trulock, Kevin
    Wilner, Bryan
    Nemer, David
    Donnellan, Eoin
    Tarakji, Khaldoun G.
    Cantillon, Daniel J.
    Varma, Niraj
    Saba, Samir F.
    Al-Khatib, Sana M.
    Wilkoff, Bruce L.
    Rickard, John W.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2021, 14 (06): : E008991
  • [45] Radiofrequency ablation in patients with obstructive hypertrophic cardiomyopathy: An updated comprehensive review and meta-analysis
    Menezes, Antonio da Silva
    Sanches, Murilo R.
    de Oliveira, Ernani
    de Oliveira, Elias J. R.
    Oliveira, Vinicius M. R.
    Moraes, Vitor R. Y.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 104 (05) : 1096 - 1106
  • [46] Clinical comparison of the two invasive treatments of hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis
    Bytyci, I
    Bajraktari, G.
    Henein, M. Y.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2699 - 2699
  • [47] Cardiac myosin inhibitors for hypertrophic cardiomyopathy: shedding light on their clinical potential
    Rao, Shiavax J.
    Forst, Beani
    Kanwal, Amreen K.
    Kanwal, Arjun
    Aronow, Wilbert S.
    Naidu, Srihari S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (01) : 1 - 4
  • [48] Cardiac Myosin Inhibitors: Unlocking Potential to Improve Treatment in Hypertrophic Cardiomyopathy
    Turer, Aslan Teyfik
    Wang, Andrew
    CIRCULATION, 2023, 147 (09) : 700 - 702
  • [49] Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis
    Kamp, Nicholas J.
    Chery, Godefroy
    Kosinski, Andrzej S.
    Desai, Milind Y.
    Wazni, Oussama
    Schmidler, Gillian Sanders
    Patel, Manesh
    Lopes, Renato D.
    Morin, Daniel P.
    Al-Khatib, Sana M.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2021, 66 : 10 - 16
  • [50] Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis
    Jansen, Mark
    Algul, Sila
    Bosman, Laurens P.
    Michels, Michelle
    van der Velden, Jolanda
    de Boer, Rudolf A.
    van Tintelen, J. Peter
    Asselbergs, Folkert W.
    Baas, Annette F.
    ESC HEART FAILURE, 2022, 9 (05): : 3418 - 3434
12345